Recursion Pharmaceuticals (RXRX) Earnings Date & Reports
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RXRX is expected to report earnings to fall 9.14% to -32 cents per share on March 04
Q4'25
Est.
$-0.33
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.12
The last earnings report on November 05 showed earnings per share of -36 cents, beating the estimate of -37 cents. With 15.27M shares outstanding, the current market capitalization sits at 2.43B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RXRX showed earnings on November 05, 2025. You can read more about the earnings report here.